Enterozyn

World's first Probiotic Solution for Gluten Sensitivity

       

KEY MARKETING ASPECTS

  • the first probiotic solution for gluten sensitivity
  • containing probiotic strain patented for improving health status of patients with diseases related to the intake of gluten
  • degradation of gluten-derrived immunogenic peptides (gliadins) triggering cytotoxic and inflammatory signals in the gut
  • improving abdominal discomfort, bloating and bowel movement
  • proprietary and exclusive formula containing a complementary probiotic strain proven to improve IBS symptoms
  • supporting a healthy and protective gut microflora
  • clinically tested in children
  • pharmacy exclusive

Facts

  • excellent survival of gastric acid
  • and the digestive system1
  • inhibits the growth of pathogenic bacteria1
  • hydrolytic activity to break down immunogenic gluten peptides causing symptoms of gluten sensitivity1
  • attenuates the production of inflammatory
  • cytokines and immune response induced by immunogenic gluten peptides2, 3, 4
  • restores healthy intestinal microflora and
  • modulating inflammatory cytokines and immune parameter in children with coeliac disease5, 6
  • improves abdominal discomfort, bloating,
  • and difficulties with defecation in children7
  • reduces acute diarrhea in children8

HOW TO USE

  • children
  • one sachet/lozenge per day
  • to be taken prior to meal
  • adults
  • two capsules per day
  • to be taken prior to meal

WHEN TO USE

  • Gluten sensitivity
  • IBS symptoms
  • Abdominal discomfort
  • Bloating
  • Constipation
  • Diarrhea
  • supplementing a protective microflora 

References

  1. Scientific report (2016)
  2. Laparra & Sanz, Int J Biol Macromol (2010)
  3. Laparra et al., PLoS  One (2012)
  4. Olivares et al., J Proteomics (2012)
  5. Medina et al. J Inflamm (2008)
  6. Olivares et al., Br J Nutr (2014)
  7. Bastürk et al., Turk J Gastroenterol (2016)
  8. Islek et al., Turk J Gastroenterol (2014)

Enterozyn® is a registered trademark by BLUESTONE PHARMA GmbH | contact: info@bluestone-pharma.com